Hermetica Superfood Encyclopedia
The Short Answer
Plumbago zeylanica's primary bioactive compound is plumbagin, a naphthoquinone concentrated at up to 81% in chloroform root extracts, which exerts antioxidant effects by elevating catalase and glutathione peroxidase while suppressing lipid peroxidation. In a rat nephrotoxicity model, oral hydroalcoholic root extract at 400 mg/kg reduced cisplatin-elevated serum creatinine by 71.67% (from 3.0 ± 0.19 to 0.85 ± 0.06 mg/dL) and serum urea by 68.2%, approaching normal renal values.
CategoryRoot
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordPlumbago zeylanica benefits
Ceylon leadwort — botanical close-up
Health Benefits
**Nephroprotection**
Hydroalcoholic root extract at 400 mg/kg orally restored kidney weight and reduced serum creatinine by 71.67% and urea by 68.2% in cisplatin-induced nephrotoxicity rat models, driven by plumbagin's antioxidant enzyme upregulation.
**Antioxidant Activity**
Plumbagin elevates catalase and glutathione peroxidase activity while reducing lipid peroxidation, providing cellular protection against oxidative stress-mediated tissue damage in preclinical models.
**Antimicrobial Effects**
Methanolic stem and leaf extracts demonstrated inhibition zones of 17 mm against Pseudomonas aeruginosa at 1200 µg/100 µL, indicating clinically relevant antibacterial activity against gram-negative pathogens.
**Antifungal Potential**
Methanolic extracts of stems and leaves show growth inhibition of fungal organisms in vitro, attributable to plumbagin's membrane-disrupting naphthoquinone structure, though specific fungal species data remain limited.
**Antihyperglycemic Properties**
Plumbagin is identified as a key contributor to blood glucose modulation in traditional use and preliminary studies, with phytochemical screening confirming flavonoids, terpenoids, and steroids that may synergistically support glycemic regulation.
**Anticancer Preliminary Activity**
Methanolic extracts tested against HCT-116 (colon) and K-562 (leukemia) cell lines at 25–800 µg/mL over 72 hours via MTT assay showed weak but detectable growth inhibition, identifying plumbagin as a candidate for further oncology research.
**Antiparasitic and Antiallergic Activity**
Plumbagin's broad bioactivity spectrum includes documented antiparasitic effects in traditional systems and preclinical antiallergic properties, consistent with its widespread ethnobotanical use across South and Southeast Asian healing traditions.
Origin & History
Natural habitat
Plumbago zeylanica L. is native to tropical and subtropical regions of South and Southeast Asia, including Sri Lanka, India, Thailand, and the Philippines, and has naturalized across Africa and the Americas. It thrives in dry, disturbed soils, roadsides, and forest margins at low to mid elevations, tolerating heat and drought conditions. The plant is a sprawling perennial shrub cultivated both wild-harvested and in home gardens across South Asian traditional medicine communities, with the root being the most pharmacologically prized part.
“Plumbago zeylanica has been employed for over two millennia in Ayurvedic medicine under the Sanskrit name 'Chitraka,' where it appears in classical texts such as Charaka Samhita as a digestive stimulant, treatment for skin diseases including leprosy and leucoderma, and as an abortifacient and emmenagogue administered via root preparations. In traditional Chinese medicine it is known as 'Bai Hua Dan' and used for rheumatic conditions and as an antimicrobial agent in topical applications. Across Southeast Asian ethnobotany—including Thai, Filipino, and Sri Lankan folk medicine—the root paste is applied to ulcers, hemorrhoids, and parasitic skin infections, while decoctions are used internally for digestive complaints and fever. The plant's notorious abortifacient properties have been documented historically across cultures, reflecting the potency of plumbagin as a uterotonic agent and underscoring the significant toxicological risks associated with unsupervised use.”Traditional Medicine
Scientific Research
The evidence base for Plumbago zeylanica consists exclusively of in vitro cell assays and preclinical rodent studies as of current literature, with no published human clinical trials reporting sample sizes, randomization, or controlled effect sizes. Key animal evidence includes a rat cisplatin nephrotoxicity model showing 71.67% creatinine reduction and 68.2% urea reduction at 400 mg/kg oral hydroalcoholic root extract, and in vitro antimicrobial data demonstrating 17 mm inhibition zones against P. aeruginosa from methanolic stem extracts at 1200 µg/100 µL. Cytotoxicity in HCT-116 and K-562 cancer cell lines at 25–800 µg/mL over 72 hours via MTT assay showed only weak, non-significant growth inhibition, limiting conclusions about anticancer potential. Overall, the scientific evidence is preliminary and insufficient to establish therapeutic dosing, efficacy, or safety in humans; transition to Phase I human trials has not been reported in the available literature.
Preparation & Dosage
Traditional preparation
**Hydroalcoholic Root Extract (Oral, Preclinical)**
400 mg/kg in rats demonstrated nephroprotective efficacy; no equivalent human dose established by allometric scaling or clinical study
**Methanolic Stem/Leaf Extract (In Vitro Antimicrobial)**
Tested at 300–1200 µg/100 µL; not applicable for oral supplementation without further bioavailability and safety data.
**Chloroform Root Extract (Plumbagin Isolation)**
Yields approximately 81% plumbagin; used for analytical and research purposes, not for direct human consumption.
**Ethanol Root Extract**
Yields approximately 13% plumbagin; used in phytochemical research and traditional decoction preparation.
**Traditional Decoction (Ethnobotanical)**
Root paste or decoction applied topically for skin diseases or administered orally in small quantities by traditional practitioners in South Asian systems; exact quantities are unspecified in clinical literature and carry safety risk due to abortifacient activity.
**Standardization**
2198 mg/mL range in leaves/branches) necessitates HPLC-based quality control
No commercially standardized supplement form for plumbagin content has been validated in human clinical trials; seasonal variation in plumbagin content (0.1220–1..
**Timing**
Not established; traditional use varies by indication and practitioner.
Nutritional Profile
Plumbago zeylanica is not consumed as a dietary food source and does not contribute meaningful macronutrients or micronutrients to the diet. Its pharmacological value resides in secondary metabolites: plumbagin (naphthoquinone, up to 81% in chloroform root extracts), 1,4-naphthalenedione (40.09% of diethyl ether fraction), oleic acid (19.95%), β-asarone (14.08%), naphtho(2,3-b)furan-2(3H)-one (7.68%), ethyl p-methoxycinnamate (4.58%), and n-hexadecanoic acid (2.18%). Phytochemical screening confirms the presence of alkaloids, terpenoids, steroids, flavonoids, quinones, phenols, tannins, and sugars in root fractions. Bioavailability of plumbagin from oral extracts has not been characterized through human pharmacokinetic studies; lipophilicity of the naphthoquinone core suggests potential for enhanced absorption with co-administration of dietary fats, though this is unconfirmed. Plumbagic acid glucosides in roots represent additional phenolic glycoside constituents with potential bioactivity.
How It Works
Mechanism of Action
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), the principal bioactive of Plumbago zeylanica, exerts antioxidant activity by upregulating endogenous enzymatic defenses including catalase and glutathione peroxidase, thereby quenching reactive oxygen species and attenuating lipid peroxidation at the cellular membrane level. As a naphthoquinone, plumbagin can undergo redox cycling to generate superoxide anions in cancer cells while paradoxically acting as an antioxidant in normal tissue contexts, a dual activity linked to its electron-accepting quinone moiety. Antimicrobial action is attributed to plumbagin's ability to disrupt bacterial membrane integrity and inhibit respiratory chain enzymes, consistent with the membrane-targeting behavior of other 1,4-naphthoquinones. Secondary compounds including 1,4-naphthalenedione (40.09%), β-asarone (14.08%), and oleic acid (19.95%) in diethyl ether root fractions may contribute additive or synergistic bioactivities across anti-inflammatory, antimicrobial, and metabolic pathways, though their independent molecular targets in Plumbago zeylanica have not been fully characterized.
Clinical Evidence
No human clinical trials for Plumbago zeylanica or isolated plumbagin have been identified in the current evidence base, and all quantified efficacy data derive from animal or cell-culture models. The most robust preclinical finding is nephroprotection in rats at 400 mg/kg/day oral hydroalcoholic root extract, achieving near-normalization of serum creatinine (0.85 ± 0.06 vs. normal 0.7 ± 0.05 mg/dL) against cisplatin-induced injury. Antimicrobial in vitro results are promising for P. aeruginosa but have not been translated to animal infection models or human pharmacokinetic studies. Confidence in clinical applicability remains low; the plant's traditional use as an abortifacient and for skin diseases lacks controlled clinical corroboration, and rigorous Phase I safety and Phase II efficacy trials in humans are absent.
Safety & Interactions
Plumbago zeylanica carries significant safety concerns: plumbagin is a documented abortifacient and uterotonic agent, making the plant absolutely contraindicated during pregnancy; traditional use as an abortifacient corroborates this risk with historical reports of severe uterine irritation. At high doses, plumbagin can induce mucosal irritation of the gastrointestinal tract, and topical root applications have historically caused vesicant (blister-inducing) reactions, reflecting the compound's caustic naphthoquinone chemistry. No formal drug interaction data exist for human use, but plumbagin's redox-cycling capacity raises theoretical concerns about antagonism with antioxidant medications and potential additive nephrotoxicity or hepatotoxicity with nephrotoxic drugs (e.g., cisplatin, NSAIDs), despite preclinical nephroprotective findings at specific doses. No maximum safe human dose has been established; all therapeutic dose ranges are extrapolated from animal models, and self-medication is strongly discouraged given the narrow therapeutic-to-toxic margin suggested by traditional risk profiles.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Plumbago zeylanica L.Ceylon leadwortChitrakaBai Hua DanChitramoolWhite leadwortDoctorbush
Frequently Asked Questions
What is plumbagin and why is it important in Plumbago zeylanica?
Plumbagin is a 5-hydroxy-2-methyl-1,4-naphthoquinone and the primary bioactive compound in Plumbago zeylanica roots, serving as both the quality marker and the principal driver of the plant's antioxidant, antimicrobial, antihyperglycemic, and anticancer properties. Chloroform root extracts can yield up to 81% plumbagin, while ethanol extracts contain approximately 13%, and seasonal variation in leaves and branches produces plumbagin concentrations ranging from 0.1220 to 1.2198 mg/mL, necessitating HPLC-based standardization for any research or therapeutic application.
Is Plumbago zeylanica safe to use during pregnancy?
Plumbago zeylanica is absolutely contraindicated during pregnancy; plumbagin is a well-documented abortifacient and uterotonic agent used historically across South and Southeast Asian traditional medicine precisely to induce abortion and stimulate uterine contractions. No safe dose in pregnancy has been established, and even topical root preparations carry systemic risk due to the caustic, vesicant nature of plumbagin; pregnant individuals should strictly avoid all forms of this plant.
What are the traditional uses of Plumbago zeylanica in Ayurvedic medicine?
In Ayurveda, Plumbago zeylanica is known as 'Chitraka' and is described in classical texts including the Charaka Samhita as a digestive stimulant (deepana), treatment for skin diseases such as leucoderma and leprosy, and as a potent emmenagogue and abortifacient. It was traditionally prepared as root paste for topical application to ulcers and skin parasites, and as decoctions or powders administered internally for fever, dyspepsia, and rheumatic complaints, often combined with Piper longum and Zingiber officinale in compound formulations such as Trikatu.
What does the research say about Plumbago zeylanica for kidney protection?
A preclinical rat study using cisplatin-induced nephrotoxicity showed that oral hydroalcoholic root extract of Plumbago zeylanica at 400 mg/kg reduced elevated serum creatinine by 71.67% (from 3.0 ± 0.19 mg/dL to 0.85 ± 0.06 mg/dL, approaching the normal value of 0.7 ± 0.05 mg/dL) and reduced serum urea by 68.2%, alongside restoration of kidney weight. These effects are attributed to plumbagin's upregulation of catalase and glutathione peroxidase and reduction of lipid peroxidation; however, no human clinical trials exist, so these findings cannot yet be translated into clinical recommendations.
What is the antimicrobial activity of Plumbago zeylanica extracts?
Methanolic stem and leaf extracts of Plumbago zeylanica demonstrated inhibition zones of 17 mm against Pseudomonas aeruginosa at a concentration of 1200 µg/100 µL in in vitro disk diffusion assays, indicating meaningful antibacterial activity against this clinically relevant gram-negative pathogen. The activity is attributed primarily to plumbagin's ability to disrupt bacterial membrane integrity and inhibit respiratory chain enzymes; however, these results are limited to in vitro conditions and have not been validated in animal infection models or human trials.
What is the most effective form of Plumbago zeylanica for kidney health?
Hydroalcoholic root extracts have demonstrated superior nephroprotective effects compared to other formulations, with studies showing 400 mg/kg doses significantly restored kidney function and reduced creatinine and urea levels in animal models. The extraction method matters because it concentrates plumbagin and other active compounds that drive antioxidant enzyme upregulation in kidney tissue. Standardized extracts containing quantified plumbagin levels provide more consistent results than raw root powder, though human clinical trials are still limited.
Who should avoid Plumbago zeylanica supplementation?
Beyond pregnant and nursing women, individuals with existing kidney disease requiring pharmaceutical management should consult their healthcare provider before using Plumbago zeylanica, as it significantly impacts kidney function markers and drug metabolism. People taking nephrotoxic medications or chemotherapy agents should also avoid this ingredient without medical supervision, since its mechanism involves upregulating detoxification pathways that could affect drug bioavailability. Those with known hypersensitivity to plumbagin or related naphthoquinones should not use this ingredient.
How does Plumbago zeylanica root compare to other traditional nephroprotective herbs in clinical evidence?
Plumbago zeylanica demonstrates particularly strong evidence for kidney protection through its plumbagin component, which directly upregulates antioxidant enzymes like catalase and glutathione peroxidase—a more specific mechanism than many comparable herbs. While traditional Ayurvedic herbs like Tribulus terrestris and Gokshura have longer historical use records, Plumbago zeylanica has modern pharmacological data showing 71.67% reduction in serum creatinine in cisplatin-induced nephrotoxicity models. However, direct head-to-head human clinical trials comparing these herbs remain absent, making relative efficacy difficult to establish definitively.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w plumbago-zeylanica-plumbago-zeylanica-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
